A major international collaboration led by Melbourne researchers has discovered that the world’s most widespread malaria parasite infects humans by hijacking a protein the body cannot live without.
The researchers were then able to successfully develop antibodies that disabled the parasite from carrying out this activity.
The study, led by the Walter and Eliza Hall Institute’s Associate Professor Wai-Hong Tham and Dr Jakub Gruszczyk, found that the deadly malaria parasite Plasmodium vivax (P. vivax) causes infection through latching onto the human transferrin receptor protein, which is crucial for iron delivery into the body’s young red blood cells.
Published today in Science, the discovery has solved a mystery that researchers have been grappling with for decades.
Associate Professor Tham, who is also a HHMI-Wellcome International Research Scholar, said the collective efforts of teams from Australia, New Zealand, Singapore, Thailand, United Kingdom, United States, Brazil and Germany had brought the world closer to a potential effective vaccine against P.vivax malaria.
“P. vivax currently inflicts a huge burden on global health. It is the most common malaria parasite in countries outside of Africa, with more than 16 million clinical cases recorded each year.
“The parasite can lie dormant in the liver for months on end without causing any symptoms, which makes it very sneaky and difficult to treat,” Associate Professor Tham said.
“We now know that P. vivax is hijacking the human transferrin receptor which is essential for transporting iron into the body’s young red blood cells.
“Being able to stop P. vivax from latching onto this receptor and infliltrating the blood is a major breakthrough and important step towards malaria elimination,” she said.
Dr Gruszczyk said once the teams understood how the parasite was gaining entry into the cells, they were able to design antibodies to block the mode of access.
“Using the Australian Synchrotron in Melbourne, we generated a 3D map of the parasite protein which is the mechanism P. vivax uses to latch onto the human transferrin receptor and enter the young red blood cells.
“This map provided an unprecedented view of the parasite protein’s shape, which guided the design of antibodies to block P. vivax from gaining entry into the human cells,” Dr Gruszczyk said.
Associate Professor Tham said they were thrilled to see the antibodies successfully block P. vivax invasion using parasites from both Thailand and Brazil. “We are now looking to include collaborative partners in the Pacific, so we can further test the effectiveness of our antibodies,” she said.
Study collaborator Dr Jonathan Abraham from Harvard University said the results of the new study aligned with a growing body of evidence that could be used to target multiple infectious diseases.
“Transferrin receptor is also co-opted by five viruses that cause Ebola-like diseases in South America. These diseases are known as New World haemorrhagic fevers.
“Our increasing understanding of how several pathogens are taking advantage of transferrin receptor, means we are getting closer to disrupting infection for a number of deadly diseases,” Dr Abraham said.
The Latest on: Malaria parasite
- Anti-mosquito fabrics for malaria preventionon June 25, 2020 at 6:40 am
Malaria causes almost a half-million deaths every year worldwide. While the majority of people affected by this mosquito-borne parasitic infection are in Africa, a smaller percentage of cases are also ...
- How deforestation helps deadly viruses jump from animals to humanson June 25, 2020 at 6:19 am
The coronavirus pandemic, suspected of originating in bats and pangolins, has brought the risk of viruses that jump from wildlife to humans into stark focus. Th ...
- Research on brain swelling in children with cerebral malaria reveals potential new treatment approachon June 25, 2020 at 5:31 am
Through investigating the causes of brain swelling in cerebral malaria—a devastating parasitic disease that is fatal for one in five children—scientists have found a potential new treatment ...
- Mass testing in Ampang after malaria detectedon June 24, 2020 at 4:11 pm
Mass blood testing for more than 600 households in two neighbourhoods in Ampang is being carried out after 14 cases of malaria were detected in the area.
- Parasitic infections are closely linked to the microbiomeon June 24, 2020 at 10:36 am
"We found that we could look at someone's microbiome and use it to predict whether someone had a gastrointestinal parasite infection," say the researchers.
- Tomocube holotomography microscopy reveals novel cholesterol membrane transport system in erythrocytes infected with fatal malaria parasiteon June 24, 2020 at 9:15 am
The first study to elucidate the dynamics of membrane cholesterol transport in erythrocytes has been successfully concluded using holotomography microscopy.
- Africa: Responding to COVID-19 Must Not Come at the Expense of Malaria Activities, Otherwise Children May Pay The Priceon June 24, 2020 at 6:43 am
Opinion - Across the world, the COVID-19 pandemic has led people to fear accessing healthcare facilities. As a paediatrician working for Médecins Sans Frontières (MSF) in Sierra Leone, and with the ...
- Different distribution of malaria parasite in left and right extremities of vertebrate hosts translates into differences in parasite transmissionon June 23, 2020 at 2:16 am
The World Health Organisation estimates that in 2018, there were 228 million cases of malaria worldwide, resulting in more than 405 000 deaths 1. African countries are disproportionally affected, and ...
- Malaria-proof yourself in these areason June 22, 2020 at 5:55 am
This could be prevented if they mapped areas that they plan to visit and take caution. There are other disease transmitted by mosquitoes that should send a chill in the spine. The Ministry of Health ...
- New discovery paves way for next generation malaria vaccineon June 17, 2020 at 7:14 am
New findings pave the way for a novel, next generation genetically attenuated parasite (GAP) vaccine against the deadliest form of malaria in humans.
via Google News and Bing News